The initial public offering (IPO) of Kolkata-based GPT Healthcare will begin accepting subscriptions on February 22, 2024, and it will end on February 26, 2024. The impending IPO’s price range hasn’t been disclosed yet, though.
The GPT Healthcare IPO is a book-built offering that consists of a 2.61 crore share offer for sale in addition to a fresh issue of ₹40 crore.
Approximately half of the issue is set aside for QIB, at least thirty-five percent is set aside for retail investors, and at least fifteen percent of the offer is set aside for NII.
Under the ILS Hospitals brand, GPT Healthcare Limited manages a network of mid-sized, full-service, multispecialty hospitals in Eastern India that offer integrated healthcare services with an emphasis on secondary and tertiary care.
The organization, which has its headquarters in Kolkata, West Bengal, provides a wide range of medical services in more than 35 specializations and subspecialties, including diabetology and internal medicine, nephrology (including kidney transplantation), general and laparoscopic surgery, obstetrics and gynecology, intensive care, gastroenterology, orthopaedics and joint replacement, neurology, and neurosurgery, as well as pediatrics and neonatology. Moreover, pharmacies and integrated diagnostic services are provided.
Between the fiscal year ending on March 31, 2023, GPT Healthcare Limited’s revenue climbed by 7.11% while its profit after tax (PAT) decreased by -6.37%.
